More Clinical Articles


Moving remote: the post-pandemic clinical trial

Lucy Fulford, (Apr 3, 2020)

Pharma is rapidly adapting its approach to trials in the face of the pandemic and there is great opportunity for far reaching improvements once this is all over

Imagining the ‘Digitome’

Andrew Stone, (Feb 28, 2020)

Dramatic advances in human health beckon if pharma can help build ‘the Digitome’, a vast data commons

RWE: A new hope for rare disease

Lucy Fulford, (Jan 30, 2020)

RWE shows great promise in helping accelerate treatments for rare disease
Access and Evidence

Into pharma's roaring twenties

Paul Simms, (Jan 14, 2020)

A new decade is here. And despite the incredible science, pharma is ill-equipped.

Telemedicine: The future of clinical trials?

Nicola Davies, (Dec 13, 2019)

There is a new surge of interest in telemedicine’s potential to optimize clinical trials, but is this what patients want?

Clinical must think outside, and inside the box

Paul Simms, (Nov 21, 2019)

From site-in-a-box to virtual/siteless trials: which new model will successfully disrupt clinical research?
Patients and Medical

Towards patient preferred trials

Katie Osborne, (Sep 18, 2019)

Putting the patient at the centre of clinical trials could be transformative
Patients and Medical

Creating a Patient Trial Community

Katie Osborne, (Aug 13, 2019)

A pioneering project promises to transform patients’ clinical trials experience and help move the trials process forward
Patients and Medical

Unleashing AI’s potential in clinical trial recruitment

Katie Osborne, (Jul 29, 2019)

Multiple innovations using AI are transforming the trial recruitment process
Access and Evidence

Putting The I in Pills

Izzy Gladstone, (Jun 27, 2019)

Individualised medicine has so far failed to live up to the hype but innovations in the field are on the cusp of disrupting the way pharma and healthcare develop and provide treatments.